Vita Life Sciences Limited (VLS.AX)

AUD 1.77

(-1.67%)

Total Debt Summary of Vita Life Sciences Limited

Vita Life Sciences Limited's latest annual total debt in 2023 was 387 Thousand AUD , down -35.61% from previous year.
Vita Life Sciences Limited's latest quarterly total debt in 2024 Q2 was 430 Thousand AUD , down 0.0% from previous quarter.
Vita Life Sciences Limited reported annual total debt of 601 Thousand AUD in 2022, up 61.13% from previous year.
Vita Life Sciences Limited reported annual total debt of 373 Thousand AUD in 2021, down -82.0% from previous year.
Vita Life Sciences Limited reported quarterly total debt of 387 Thousand AUD for 2023 Q4, down 0.0% from previous quarter.
Vita Life Sciences Limited reported quarterly total debt of 387 Thousand AUD for 2023 FY, down -35.61% from previous quarter.

Annual Total Debt Chart of Vita Life Sciences Limited (2023 - 2007)

Historical Annual Total Debt of Vita Life Sciences Limited (2023 - 2007)

Year	Total Debt	Total Debt Growth
2023	387 Thousand AUD	-35.61%
2022	601 Thousand AUD	61.13%
2021	373 Thousand AUD	-82.0%
2020	2.07 Million AUD	-11.79%
2019	2.34 Million AUD	13.26%
2018	2.07 Million AUD	-6.45%
2017	2.21 Million AUD	-9.88%
2016	2.46 Million AUD	-12.46%
2015	2.81 Million AUD	-16.22%
2014	3.35 Million AUD	0.0%
2013	- AUD	0.0%
2012	- AUD	0.0%
2011	- AUD	-100.0%
2010	1.81 Million AUD	35.95%
2009	1.33 Million AUD	3.71%
2008	1.28 Million AUD	57.32%
2007	817.57 Thousand AUD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	430 Thousand AUD	0.0%
2023 Q4	387 Thousand AUD	0.0%
2023 FY	387 Thousand AUD	-35.61%
2023 Q2	465 Thousand AUD	0.0%
2022 Q4	601 Thousand AUD	0.0%
2022 FY	601 Thousand AUD	61.13%
2022 Q2	536 Thousand AUD	0.0%
2021 FY	373 Thousand AUD	-82.0%
2021 Q2	434 Thousand AUD	0.0%
2021 Q4	373 Thousand AUD	0.0%
2020 FY	2.07 Million AUD	-11.79%
2020 Q2	2.21 Million AUD	0.0%
2020 Q4	2.07 Million AUD	0.0%
2019 Q2	2.41 Million AUD	0.0%
2019 FY	2.34 Million AUD	13.26%
2019 Q4	2.34 Million AUD	0.0%
2018 Q2	2.19 Million AUD	0.0%
2018 FY	2.07 Million AUD	-6.45%
2018 Q4	2.07 Million AUD	0.0%
2017 Q2	2.26 Million AUD	0.0%
2017 Q4	2.21 Million AUD	0.0%
2017 FY	2.21 Million AUD	-9.88%
2016 Q2	2.81 Million AUD	0.0%
2016 FY	2.46 Million AUD	-12.46%
2016 Q4	2.46 Million AUD	0.0%
2015 Q2	3.18 Million AUD	0.0%
2015 Q4	2.81 Million AUD	0.0%
2015 FY	2.81 Million AUD	-16.22%
2014 FY	3.35 Million AUD	0.0%
2014 Q4	3.35 Million AUD	0.0%
2014 Q2	- AUD	0.0%
2013 Q2	- AUD	0.0%
2013 FY	- AUD	0.0%
2013 Q4	- AUD	0.0%
2012 FY	- AUD	0.0%
2012 Q4	- AUD	0.0%
2011 FY	- AUD	-100.0%
2011 Q4	- AUD	0.0%
2010 Q4	1.81 Million AUD	0.0%
2010 FY	1.81 Million AUD	35.95%
2009 Q4	1.33 Million AUD	0.0%
2009 FY	1.33 Million AUD	3.71%
2008 FY	1.28 Million AUD	57.32%
2008 Q4	1.28 Million AUD	0.0%
2007 FY	817.57 Thousand AUD	0.0%

Peer Total Debt Comparison of Vita Life Sciences Limited

Name	Total Debt	Total Debt Difference
Althea Group Holdings Limited	972 Thousand AUD	60.185%
Cann Group Limited	72.46 Million AUD	99.466%
ECS Botanics Holdings Ltd	1.02 Million AUD	62.203%
Ecofibre Limited	25.49 Million AUD	98.482%
Elixinol Wellness Limited	1.26 Million AUD	69.334%
Hygrovest Limited	- AUD	-Infinity%
IDT Australia Limited	4.46 Million AUD	91.338%
Invion Limited	- AUD	-Infinity%
Little Green Pharma Ltd	11.86 Million AUD	96.739%
Live Verdure Ltd	22.29 Thousand AUD	-1636.205%
Medical Developments International Limited	2.28 Million AUD	83.071%
Vitura Health Limited	5.31 Million AUD	92.724%